q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

May 2013 Summary of the Most Recent Updates for the Medicare Part D Plan Formularies (Drug Lists)

Category: Monthly Formulary Changes
Published: May, 28 2013 05:05:46
< Previous
Next >
The most recent (May 2013) Medicare Part D plan formulary data (or drug lists) updates include the addition of 131 new National Drug Codes (NDC) to the Medicare Part D program.  These represent 77 different drugs, many with multiple strengths or delivery forms.

The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

There are many reasons for NDCs to be added to the Medicare Part D program, a summary is a follows:

Reason for NDC Addition Occurences
new delivery form/manfuacturer 4
new delivery form/strength 2
new delivery form/strength/manfuacturer 1
new drug 25
new drug strength 20
new drug with multiple strengths 45
new drug, strength and delivery form 4
new drug, strength and manufacturer 3
new manufacturer 5
new strength and manufacturer 22

The majority of the 131 new NDCs included new drug strengths and in some cases manufacturers. Two new generic alternatives were introduced:

  • VALSARTAN-HCTZ generic equivalent for Diovan HCT® is on 72 PDP and 246 MAPD formularies
  • RIZATRIPTAN generic equivalent for Maxalt-MLT® is on 51 PDP and 197 MAPD formularies

The following 131 manufacturer / drug / strength / packaging combinations (NDCs) were added to one or more Medicare Part D formularies in the most recent updates. You can click on the NDC or Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
00024583102 AUVI-Q 0.15 MG AUTO-INJECTOR new drug/strength
00024583302 AUVI-Q 0.3 MG AUTO-INJECTOR new drug/strength
51672130903 BETAMETHASONE DP AUG 0.05% GEL new drug
45802005302 betamethasone valer 0.12% foam new strength/manufacturer
10370010150 BUPROPION HCL XL 150 MG TABLET new manufacturer
00591333205 Bupropion Hydrochloride XL 300mg/1 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE new drug strength
00409477723 Ciprofloxacin and Dextrose 2mg/mL 24 BAG in 1 CASE / 100 mL in 1 BAG new drug
00527138104 Clindamycin Hydrochloride 75mg/1 200 CAPSULE in 1 BOTTLE new strength/manufacturer
00781328809 clindamycin-d5w 300 mg/50 ml new drug/strength/manufacturer
00781328909 clindamycin-d5w 600 mg/50 ml new drug/strength/manufacturer
00781329009 clindamycin-d5w 900 mg/50 ml new drug/strength/manufacturer
42388001214 COMETRIQ 100 MG DAILY-DOSE PK new drug/strength
42388001114 COMETRIQ 140 MG DAILY-DOSE PK new drug/strength
42388001314 COMETRIQ 60 MG DAILY-DOSE PACK new drug/strength
00172731046 Cyclosporine 25mg/1 30 BLISTER PACK in 1 CARTON / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK new drug strength
00430075327 DELZICOL DR 400 MG CAPSULE new drug
55111055131 desloratadine 2.5 mg odt new strength/manufacturer
55111036031 desloratadine 5 mg odt new manufacturer
68180090213 DROSPIRENONE-ETH ESTRADIOL TAB new drug
00069010601 ELELYSO 200 UNITS VIAL new drug
00003089321 ELIQUIS 2.5 MG TABLET new drug/strength
00003089421 ELIQUIS 5 MG TABLET new drug/strength
00781312293 ENOXAPARIN 300 MG/3 ML VIAL new strength/manufacturer
51991062328 Estradiol / Norethindrone Acetate 0.5; 0.1mg/1; mg/1 1 BLISTER PACK in 1 CARTON / 28 TABLET, FILM C new drug strength
00078050315 EXELON 13.3 MG/24HR PATCH new drug strength
49909000530 FLUOXETINE HCL 60 MG TABLET new drug strength
68875010301 GATTEX 5 MG ONE-VIAL KIT new drug
52544004154 GELNIQUE 3% GEL new delivery form/strength
52544020431 GENERESS FE CHEWABLE TABLET new drug
00603359017 gildagia 0.4 mg-0.035 mg tab new drug
00085049201 guanidine hcl 125 mg tablet new strength/manufacturer
76189053560 ICLUSIG 15 MG TABLET new drug/strength
76189053430 ICLUSIG 45 MG TABLET new drug/strength
00065175007 ILEVRO 0.3% OPHTH DROPS new drug
00006053354 JUVISYNC 50-10 MG TABLET new drug strength
00006053554 JUVISYNC 50-20 MG TABLET new drug strength
00006053754 JUVISYNC 50-40 MG TABLET new drug strength
76431011001 JUXTAPID 10 MG CAPSULE new drug/strength
76431012001 JUXTAPID 20 MG CAPSULE new drug/strength
76431010501 JUXTAPID 5 MG CAPSULE new drug/strength
64764033760 KAZANO 12.5-1,000 MG TABLET new drug/strength
64764033560 KAZANO 12.5-500 MG TABLET new drug/strength
76346007301 KORLYM 300 MG TABLET new drug
00173076100 LAMICTAL XR 300mg/1 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE new drug strength
64679027302 LAMOTRIGINE ER 100 MG TABLET new drug strength
49884056411 lamotrigine er 200 mg tablet new strength/manufacturer
49884056111 lamotrigine er 25 mg tablet new strength/manufacturer
49884060411 lamotrigine er 250 mg tablet new strength/manufacturer
49884060511 lamotrigine er 300 mg tablet new strength/manufacturer
49884056211 lamotrigine er 50 mg tablet new strength/manufacturer
63402031230 LATUDA 120 MG TABLET new drug strength
16714034004 LEVONEST-28 TABLET new drug
68180084313 levonor-eth estrad 0.15-0.03 new drug
68025004610 LORZONE 375 MG TABLET new drug/strength
68025004710 LORZONE 750 MG TABLET new drug/strength
55566210001 LYSTEDA 650mg/1 new drug
49884090252 mafenide acetate 50 gm powd pk new drug
68180033707 METFORMIN HCL ER 1,000 MG TAB new manufacturer
00093529201 methylphenidate cd 50 mg cap new drug/strength
00093529301 methylphenidate cd 60 mg cap new drug/strength
00406012701 METHYLPHENIDATE ER 27 MG TAB new strength/manufacturer
68968663708 MINIVELLE 0.0375 MG PATCH new drug/strength
68968665008 MINIVELLE 0.05 MG PATCH new drug/strength
68968667508 MINIVELLE 0.075 MG PATCH new drug/strength
68968661008 MINIVELLE 0.1 MG PATCH new drug/strength
43386016006 misoprostol 100 mcg tablet new drug strength
55111076303 montelukast sod 4 mg granules new delivery form/manufacturer
68462056435 mupirocin 2% cream new delivery form/manufacturer
64764012530 NESINA 12.5 MG TABLET new drug/strength
64764025030 NESINA 25 MG TABLET new drug/strength
64764062530 NESINA 6.25 MG TABLET new drug/strength
00186402501 NEXIUM DR 2.5 MG PACKET new drug strength
00186405001 NEXIUM DR 5 MG PACKET new drug strength
43066015010 Nexterone 150mg/100mL 100 mL in 1 BAG new drug/strength
43066036020 Nexterone 360mg/200mL 200 mL in 1 BAG new drug/strength
65224070711 OMECLAMOX-PAK COMBO PACK new drug
00259142028 ONMEL 200 MG TABLET new drug
64764012103 OSENI 12.5-15 MG TABLET new drug/strength
64764012303 OSENI 12.5-30 MG TABLET new drug/strength
64764012403 OSENI 12.5-45 MG TABLET new drug/strength
64764025103 OSENI 25-15 MG TABLET new drug/strength
64764025303 OSENI 25-30 MG TABLET new drug/strength
64764025403 OSENI 25-45 MG TABLET new drug/strength
00054019959 OXCARBAZEPINE 300 MG/5 ML SUSP new delivery form/manufacturer
66689040316 OXYCODONE HCL 5 MG/5 ML SOL new strength/manufacturer
10702005601 OXYCODONE HYDROCHLORIDE 10mg/1 100 TABLET BOTTLE new strength/manufacturer
10702005701 OXYCODONE HYDROCHLORIDE 20mg/1 100 TABLET BOTTLE new strength/manufacturer
00115123201 oxymorphone hcl er 10 mg tab new manufacturer
00115123301 oxymorphone hcl er 20 mg tab new strength/manufacturer
00115131701 oxymorphone hcl er 30 mg tab new strength/manufacturer
00115123401 oxymorphone hcl er 40 mg tab new strength/manufacturer
00115123101 oxymorphone hcl er 5 mg tablet new strength/manufacturer
17478006914 pantoprazole sodium 40 mg vial new manufacturer
50242014501 PERJETA 420 MG/14 ML VIAL new drug
00378385005 phenytoin 50 mg tablet chew new delivery form/manufacturer
00781563431 pioglitaz-glimepir 30-2 mg tab new strength/manufacturer
00781563531 pioglitaz-glimepir 30-4 mg tab new strength/manufacturer
59572050100 POMALYST 1 MG CAPSULE new drug/strength
59572050200 POMALYST 2 MG CAPSULE new drug/strength
59572050300 POMALYST 3 MG CAPSULE new drug/strength
59572050400 POMALYST 4 MG CAPSULE new drug/strength
00178058208 PREDNISOLONE SOD PH 25 MG/5 ML new strength/manufacturer
59676056630 PREZISTA 800 MG TABLET new drug strength
00064360045 PRUDOXIN 50mg/g 45 g in 1 TUBE new drug
00093300256 QUININE SULFATE 324 MG CAPSULE new drug strength
17350001505 RESCULA 0.15% EYE DROPS new drug
00378370259 rizatriptan 10 mg odt new drug/strength/delivery form
51991035578 rizatriptan 10 mg tablet new drug/strength/delivery form
00378370159 rizatriptan 5 mg odt new drug/strength/delivery form
65862059912 rizatriptan 5 mg tablet new drug/strength/delivery form
00074345590 Simcor ER 1000; 20mg/1; mg 90 FILM COATED TABLET BOTTLE new delivery form/strength
42799011301 STAVUDINE 1 MG/ML SOLUTION new delivery form/strength/manufacturer
12496121203 SUBOXONE 12 MG-3 MG SL FILM new drug strength
12496120403 SUBOXONE 4 MG-1 MG SL FILM new drug strength
43538090112 SYNALAR 0.025% CREAM KIT new drug
63459017714 SYNRIBO 3.5 MG/ML VIAL new drug
00591372030 tranexamic acid 650 mg tablet new drug strength
00591363630 TROSPIUM CHLORIDE ER 60 MG CAP new strength/manufacturer
68012030930 UCERIS 9 MG ER TABLET new drug
58914000310 ULTRESA DR 13,800 UNIT CAPSULE new drug/strength
58914000510 ULTRESA DR 23,000 UNIT CAPSULE new drug/strength
58914001910 ULTRESA DR ULTRESA DR 20,700 UNIT CAPSULE UNIT CAPSULE new drug/strength
00378632205 VALSARTAN-HCTZ 160-12.5 MG TAB new drug/strength
00378632377 VALSARTAN-HCTZ 160-25 MG TAB new drug/strength
00378632405 VALSARTAN-HCTZ 320-12.5 MG TAB new drug/strength
00378632505 VALSARTAN-HCTZ 320-25 MG TAB new drug/strength
00378632177 VALSARTAN-HCTZ 80-12.5 MG TAB new drug/strength
50633021011 VORAXAZE 1,000 UNIT VIAL new drug
59630091210 XODOL 5-300 TABLET new drug strength
00024584001 ZALTRAP 100 MG/4 ML VIAL new drug
52544029231 ZENCHENT FE TABLET CHEWABLE new drug

You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at Q1Medicare.com/FormularyBrowser or compare how any medication is covered on all Medicare plans in your service area using our Q1Medicare.com/DrugFinder.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.